Quarterly report [Sections 13 or 15(d)]

Condensed Balance Sheets

v3.25.4
Condensed Balance Sheets - USD ($)
Dec. 31, 2025
Jun. 30, 2025
Current assets:    
Cash and cash equivalents $ 9,041,570 $ 11,627,849
Grant receivable 56,783 73,218
Prepaid expenses 175,413 261,439
Total current assets 9,273,766 11,962,506
Other assets:    
Loan commitment fees 148,231 183,110
Total assets 9,421,997 12,145,616
Current liabilities:    
Accounts payable 554,862 224,175
Accrued expenses 930,784 263,513
Total liabilities 1,485,646 487,688
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value; 2,000,000 shares authorized, no shares issued or outstanding at December 31, 2025 and June 30, 2025
Common stock, $0.001 par value; 75,000,000 shares authorized and 41,084,731 shares issued and outstanding at December 31, 2025 and June 30, 2025 41,086 41,086
Additional paid-in capital 85,941,523 85,505,349
Accumulated deficit (78,046,258) (73,888,507)
Total stockholders’ equity 7,936,351 11,657,928
Total liabilities and stockholders’ equity $ 9,421,997 $ 12,145,616